{"id":1227,"date":"2023-11-20T09:00:00","date_gmt":"2023-11-20T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/dr-li-xiaoyi-benjamin-founder-of-lees-pharm-was-invited-to-participate-in-the-annual-rare-diseases-symposium-2023\/"},"modified":"2026-09-24T09:22:14","modified_gmt":"2026-09-24T09:22:14","slug":"dr-li-xiaoyi-benjamin-founder-of-lees-pharm-was-invited-to-participate-in-the-annual-rare-diseases-symposium-2023","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/dr-li-xiaoyi-benjamin-founder-of-lees-pharm-was-invited-to-participate-in-the-annual-rare-diseases-symposium-2023\/","title":{"rendered":"Dr. LI Xiaoyi Benjamin, Founder of Lee\u2019s Pharm, was invited to participate in the annual \u201cRare Diseases Symposium 2023\u201d"},"content":{"rendered":"

11 November 2023, the \u201cRare Diseases Symposium\u201d organized by Rare Disease Hong Kong (RDHK) was successfully held with the theme of “Healthy China, leaving no one behind: how Hong Kong can keep up the pace of the Mainland\u2019s rare disease policy”. The symposium brought together experts in the field of rare diseases, representatives from the biotechnology sector and rare disease patients\/caregivers from Hong Kong and the Mainland, to explore how Hong Kong can draw on the progress made in the Mainland to proactively address the challenges of rare diseases and to provide better diagnosis, treatment and support to patients. Dr LI Xiaoyi, founder of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, HKEx:00950), was invited to participate in the expert discussion session of the symposium.<\/p>\n